These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6452883

  • 1. Metabolism of zimelidine in rat, dog and man. Identification and synthesis of the principal metabolites.
    Lundström J, Högberg T, Gosztonyi T, de Paulis T.
    Arzneimittelforschung; 1981; 31(3):486-94. PubMed ID: 6452883
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of zimelidine in humans--plasma levels and urinary excretion of zimelidine and norzimelidine after intravenous and oral administration of zimelidine.
    Love BL, Moore RG, Thomas J, Chaturvedi S.
    Eur J Clin Pharmacol; 1981; 20(2):135-9. PubMed ID: 6455297
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Doxylamine metabolism in rat and monkey.
    Ganes DA, Hindmarsh KW, Midha KK.
    Xenobiotica; 1986 Sep; 16(9):781-94. PubMed ID: 3765658
    [Abstract] [Full Text] [Related]

  • 8. Biotransformation of prochiral 2-phenyl-1,3-di(4-pyridyl)-2-propanol to a chiral N-oxide metabolite.
    Schwartz MA, Williams TH, Kolis SJ, Postma E, Sasso GJ.
    Drug Metab Dispos; 1978 Sep; 6(6):647-53. PubMed ID: 33027
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM, D'Souza RA, Jordan AC, King CD, Smith SM, Phillips PJ, McCormick AD, Roberts DW.
    J Pharm Biomed Anal; 2007 Feb 19; 43(3):1065-77. PubMed ID: 17030109
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Species differences in the in vitro metabolism of EGYT-475, a new antidepressant agent.
    Fonyó M, Guttmann A, Magyar K.
    Pol J Pharmacol Pharm; 1987 Feb 19; 39(2):129-34. PubMed ID: 3432158
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [AR-L 115 BS, comparison of human metabolite pattern and biotransformation with other species].
    Roth W, Prox A, Reuter A, Schmid J, Zimmer A, Zipp H.
    Arzneimittelforschung; 1981 Feb 19; 31(1a):232-5. PubMed ID: 7195228
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Elucidation of phase I and phase II metabolic pathways of rhein: species differences and their potential relevance.
    Dahms M, Lotz R, Lang W, Renner U, Bayer E, Spahn-Langguth H.
    Drug Metab Dispos; 1997 Apr 19; 25(4):442-52. PubMed ID: 9107544
    [Abstract] [Full Text] [Related]

  • 20. [Adverse effects and zimelidine therapy. Headache, muscle pain and liver involvement--a new disease entity in zimelidine therapy].
    Paulsen O, Nilsson LM, Sellin M, Osterlind A, Lundgren M, Fahlesson P.
    Lakartidningen; 1983 Jan 05; 80(1-2):31-2. PubMed ID: 6220186
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.